News / News

DASEA®'s 3D-bioengineered human umbilical cord mesenchymal stem cell-derived exosomes successfully obtain dual CBER & CDER filings from US FDA

author:REGEN-αGEEK

page views:1751

2025-01-09

share

On January 7, 2025, REGEN-αGEEK kicked off the new year with major news: its human umbilical cord mesenchymal stem cell-derived exosomes, prepared using the self-developed DASEA® bio-manufacturing platform with 3D cultivation, have successfully obtained dual Drug Master File (DMF) filings with both the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER) under the US Food and Drug Administration (FDA).


Discover regenerative wonders
with REGEN-αGEEK

WeChat Official Account
x-index2.png
WeChat Channels
视频号二维码.png

电话icon(1).svg +86-0755-26412015

email.svg enquiry@regengeek.com

dz.svg Headquarters: No. 301, Building 6, Juanhu Science and Innovation Park, No. 500, Shuiyue Pavilion East Road, Xiashi Street, Haining City, Jiaxing City, Zhejiang Province, China.

© 2024 REGEN-αGEEK (Haining) Biotechnology Co., Ltd.

x-slide1.png
x-slide2.svg Click here for the latest cell industry preparation solutions